ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLOV Clover Health Investments Corporation

0.82
-0.0433 (-5.02%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Clover Health Investments Corporation NASDAQ:CLOV NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0433 -5.02% 0.82 0.75 0.90 0.867 0.7879 0.8464 6,574,262 05:00:01

PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent

08/01/2024 10:00pm

GlobeNewswire Inc.


Clover Health Investments (NASDAQ:CLOV)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Clover Health Investments Charts.

Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today released research demonstrating Clover Assistant’s impact on medication adherence. The paper, Clover Assistant Use and Medication Adherence for Common Chronic Conditions, examines the correlation between Primary Care Physician (PCP) use of Clover Assistant and levels of adherence to prescribed medications for common chronic conditions including diabetes, high blood pressure, and high cholesterol.

The lead author of the study, Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant, Adjunct Professor at Yale, and practicing cardiologist said, “Clinicians have no idea if patients pick up their prescribed medications at the pharmacy. This is a glaring blindspot. While it may seem simple, letting doctors know that their patients have not picked up their refills can prompt conversations to understand the root cause of the non-adherence and drive meaningful increases in medication fills, as our research shows. We know that taking medications regularly for chronic health conditions lowers complications and reduces healthcare costs.”

This is the third retrospective data analysis conducted by the company to measure the clinical impact of Clover Assistant on the identification and management of chronic diseases. The previous analyses focus on the diagnosis, treatment and progression of Diabetes and Chronic Kidney Disease.

To learn more about Clover Assistant visit: www.cloverassistant.com

About Clover HealthClover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease.

Press Contact:Andrew Still-Baxterpress@cloverhealth.com

Investor Relations Contact:Ryan Schmidtinvestors@cloverhealth.com

1 Year Clover Health Investments Chart

1 Year Clover Health Investments Chart

1 Month Clover Health Investments Chart

1 Month Clover Health Investments Chart

Your Recent History

Delayed Upgrade Clock